Search Within

Erin M McGovern

Formats
  1. Meeting Abstract (14)
  2. Journal Article (11)
Groups
  1. Adult Leukemia (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Hematologic Malignancies, Division of (25)
  5. Executive Committee, Center for Hematologic Malignancies (17)
  6. GSK Faculty (17)

More Groups

People
  1. Ross Levine (17)
  2. Noushin Rahnamay Farnoud (16)
  3. Raajit Rampal (15)
  4. Minal Patel (13)
  5. Juan Arango Ossa (9)
  6. Christopher Famulare (8)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (7)

More Years

Publications
  1. Blood (16)
  2. Blood Advances (2)
  3. Clinical Cancer Research (2)
  4. American Journal of Hematology (1)
  5. Cancer Cell (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. American Association for Cancer Research (2)
  3. Amer Soc Clinical Investigation Inc (1)
  4. Cell Press (1)
  5. Elsevier Ltd (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of the global methylation profile of accelerated and blast phase myeloproliferative neoplasms and its association with response to decitabine-based therapy
    Meeting Abstract

    Rampal, R. K.; Yang, Q.; Koche, R. P.; McGovern, E.; Famulare, C.; Weinberg, R. S.; Mascarenhas, J.; Levine, R. L.; Hoffman, R.; Figueroa, M. E.
    Blood (2020)

    Fulltext@MSK | Save
  • Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin
    Journal Article

    Marcellino, B. K.; Farnoud, N.; Cassinat, B.; Lu, M.; Verger, E.; McGovern, E.; Patel, M.; Medina-Martinez, J.; Levine, M. F.; Arango Ossa, J. E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase
    Journal Article

    Mascarenhas, J. O.; Rampal, R. K.; Kosiorek, H. E.; Bhave, R.; Hexner, E.; Wang, E. S.; Gerds, A.; Abboud, C. N.; Kremyanskaya, M.; Berenzon, D.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • The genetic architecture of myeloproliferative neoplasms-blast phase (MPN-BP) stem cells
    Meeting Abstract

    Wang, X.; Rampal, R. K.; Hu, C. S.; Farnoud, N.; Famulare, C.; Patel, M. A.; McGovern, E.; Hoffman, R.
    Blood (2019)

    Fulltext@MSK | Save
  • Evaluation of tagraxofusp (SL-401) alone and in combination with ruxolitinib for the treatment of myeloproliferative neoplasms
    Meeting Abstract

    Krishnan, A.; Pagane, M.; Roshal, M.; McGovern, E.; Stone-Molloy, Z.; Chen, J.; Brooks, C.; Levine, R. L.; Rampal, R. K.
    Blood (2019)

    Fulltext@MSK | Save
  • Landscape of TP53 mutations in MPN
    Meeting Abstract

    Farnoud, N.; Famulare, C.; Papaemmanuil, E.; McGovern, E.; Medina, J.; Arango Ossa, J. E.; Rampal, R. K.; Li, B.; Levine, R. L.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes
    Meeting Abstract

    Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
    Blood (2019)

    Fulltext@MSK | Save
  • Identifying cytokine biomarkers of response to pegylated-interferon therapy in polycythemia vera and essential thrombocythemia: Correlative analysis from the MPN-RC 111/112 trials
    Meeting Abstract

    Dunbar, A.; Kosiorek, H. E.; Krishnan, A.; McGovern, E.; Park, Y.; Patel, M. A.; Singer Weinberg, R.; Yacoub, A.; Dueck, A. C.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Expansion of prior existing TP53 mutated clones in polycythemia vera patients treated with idasanutlin
    Meeting Abstract

    Marcellino, B.; Cassinat, B.; Farnoud, N.; Lu, M.; Verger, E.; McGovern, E.; Patel, M. A.; Kosiorek, H. E.; Mehrotra, M.; Houldsworth, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save